International Stem Cell Corporation Treated Real Estate Icon Kevin Weeks
January 11, 2018 08:45 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Jan. 11, 2018 (GLOBE NEWSWIRE) -- via Network NewsWire – International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a...
International Stem Cell Corporation Doses 7th Patient in Clinical Trial for Parkinson's Disease
November 29, 2017 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical stage...
International Stem Cell Corporation Doses 7th Patient in Clinical Trial for Parkinson's Disease
November 29, 2017 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical stage...
International Stem Cell Corporation Announces Operating Results for the Three and Nine-Months ended September 30, 2017
November 17, 2017 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Nov. 17, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical stage...
International Stem Cell Corporation Announces Positive Interim Clinical Results for Parkinson's Disease Clinical Trial
November 13, 2017 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and...
International Stem Cell Corporation to Present Six-Month Results of Neural Stem Cell Transplantation for Parkinson's Disease at Neuroscience 2017
November 08, 2017 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Nov. 08, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies and...
International Stem Cell Corporation Developed 3D Bioprinting Technology Targeted to Treat Liver Diseases
October 09, 2017 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Oct. 09, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation to Expand its Revenue Generating Biomedical Businesses to Support Ongoing and Future Clinical Trials
September 26, 2017 08:30 ET
|
International Stem Cell Corporation
H1 2017 operating income from ISCO’s revenue generating subsidiaries demonstrated an increase of 51% compared to its income in H1 2016, while H1 2017 revenue was $3.8 million. Edison Investment...
International Stem Cell Corporation to Move Forward with Traumatic Brain Injury Phase II Clinical Trial
September 20, 2017 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Sept. 20, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage...
International Stem Cell Corporation Reports Progress in Phase I Clinical Trial for Parkinson's Disease
September 07, 2017 08:30 ET
|
International Stem Cell Corporation
CARLSBAD, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies...